Work

Phase II-Studie zur Behandlung des vorbehandelten, fortgeschrittenen nicht-kleinzelligen Bronchialkarzinoms (NSCLC) mit Sorafenib (BAY 43–9006)

Year: 2006

Type: article

Study design: Clinical Trial

Source: Pneumologie

DOI: 10.1055/s-2006-933785

Authors: A Lange, U Gatzemeier, G Blumenschein, I Bernard, K Burk, M Reck

Institutions: LungenClinic Grosshansdorf, The University of Texas MD Anderson Cancer Center, Bayer (Germany)

Language: German

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2561840328

FWCI: 0.264

Cites:

Cited by: 1

Related to: 10